ACRV - CIK 0001781174
Acrivon Therapeutics, Inc. trades as ACRV. This page tracks Acrivon Therapeutics, Inc. through 321 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Proxy materials | DEFA14A | 2026-05-22 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-20 |
The largest companies sharing Acrivon Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Acrivon Therapeutics, Inc. reported a net loss of $77.91M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.